Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic Shock
Overview
Authors
Affiliations
Background: Risk stratifying patients with cardiogenic shock (CS) is a major unmet need. The recently proposed Society for Cardiovascular Angiography and Interventions (SCAI) stages as an approach to identify patients at risk for in-hospital mortality remains under investigation. We studied the utility of the SCAI stages and further explored the impact of hemodynamic congestion on clinical outcomes.
Methods: The CS Working Group registry includes patients with CS from 8 medical centers enrolled between 2016 and 2019. Patients were classified by the maximum SCAI stage (B-E) reached during their hospital stay according to drug and device utilization. In-hospital mortality was evaluated for association with SCAI stages and hemodynamic congestion.
Results: Of the 1414 patients with CS, the majority were due to decompensated heart failure (50%) or myocardial infarction (MI; 35%). In-hospital mortality was 31% for the total cohort, but higher among patients with MI (41% versus 26%, MI versus heart failure, <0.0001). Risk for in-hospital mortality was associated with increasing SCAI stage (odds ratio [95% CI], 3.25 [2.63-4.02]) in both MI and heart failure cohorts. Hemodynamic data was available in 1116 (79%) patients. Elevated biventricular filling pressures were common among patients with CS, and right atrial pressure was associated with increased mortality and higher SCAI Stage.
Conclusions: Our findings support an association between the proposed SCAI staging system and in-hospital mortality among patient with heart failure and MI. We further identify that venous congestion is common and identifies patients with CS at high risk for in-hospital mortality. These findings provide may inform future management protocols and clinical studies.
Rajan R, Al Jarallah M, Daoulah A, Panduranga P, Elmahrouk A, Mohamed Al Rawahi A J Soc Cardiovasc Angiogr Interv. 2025; 4(1):102461.
PMID: 40061415 PMC: 11887555. DOI: 10.1016/j.jscai.2024.102461.
El-Mughayyar D, Marshall T, DSouza K, MacLeod J, McCoy A, Morris S CJC Open. 2025; 7(2):231-238.
PMID: 40060208 PMC: 11886362. DOI: 10.1016/j.cjco.2024.11.007.
Ortega-Hernandez J, Gonzalez-Pacheco H, Araiza-Garaygordobil D, Gopar-Nieto R, Sierra-Lara-Martinez D, Manzur-Sandoval D Front Cardiovasc Med. 2025; 12:1461714.
PMID: 40017516 PMC: 11865078. DOI: 10.3389/fcvm.2025.1461714.
Kreutz J, Harbaum L, Barutcu C, Rehman A, Patsalis N, Mihali K Biomedicines. 2025; 13(2).
PMID: 40002736 PMC: 11853450. DOI: 10.3390/biomedicines13020324.
Tani A, Aramaki K, Uno S, Morisako N, Hagiwara T, Iwasaki T Heart Vessels. 2025; .
PMID: 39864025 DOI: 10.1007/s00380-025-02513-x.